Copy
View this email in your browser

Press Release

For Immediate Release
30 May 2019
                                                                             

Vaping Education and Balanced Information important this World Smokefree Day


Asthma and Respiratory Foundation NZ (ARFNZ) marks World Smoke Free Day tomorrow (May 31) with a call for more education to the public on vaping and e-cigarettes.
 
The Foundation stresses that the promotion of e-cigarettes being a healthier alternative to cigarette smoking needs to be a balanced discussion.
  
Letitia O’Dwyer, CEO of ARFNZ comments: “We applaud the Health Promotion Agency (HPA) and the Ministry of Health (MoH) on advising that vaping could assist some people to stop smoking when provided with behavioural support, but we also hope that the educational information recognises that these products are not without harm themselves.”
 
The Foundation also highlights the lack of consultation with respiratory physicians throughout the development of the educational information for the public, “ARFNZ has repeatedly requested that a practicing respiratory physician who sees patients with respiratory conditions and is a member of The Thoracic Society of Australia and New Zealand (TSANZ) be appointed to both the MoH and HPA advisory panels – but this never happened” Letitia comments.
 
This lack of consultation has now been viewed as “biased” towards suppliers and retailers of vaping products, Letitia adds, “It seems to be a real conflict of interest, to have people involved with the international electronic cigarette industry, vaping business owners, and retail store managers who specialise in selling these products being decision makers as to what educational material goes out to the public.”
 
Dr Stuart Jones, President of the Thoracic Society and Medical Director of the Asthma and Respiratory Foundation adds, “We must remember that these vaping and e-cigarette devices are consumer products and none of them have been through the rigorous assessment required to be a medical product. The 95% safer claim that these companies state is also unsubstantiated, basing this statistic off an old paper with limited scientific evidence, and therefore should not be used when promoting e-cigarettes.”
 
To balance the discussion, Dr Jones requests that the findings of current and ongoing research be considered when encouraging vaping as an alternative to smoking, “Although less harmful than cigarettes, we now have a growing body of evidence that these devices do cause inflammation and damage the airways, in different ways to traditional smoking. Additionally, these products should only be used for smoking cessation after proven medical therapies have been tried and failed, paired with behavioural support. It is also essential that when using vaping devices as a cessation product that there is a complete switch to avoid dual use of cigarettes and vaping, as this can potentially end up harming the airways further.”
 
ARFNZ also wants the government to consider the 87% of non-smoking adults 1 (15 years + as per ASH website) who may be affected by the second hand vape that these vaping devices emit, “If the Smoke Free Environments Act doesn’t apply to vaping or e-cigarettes, this means that the 1 in 8 adults with a chronic respiratory condition within New Zealand could be exposed to vape while at an outdoor event or restaurant – and that may worsen their condition” Letitia states.
 
Letitia continues, “Of course we are committed to Smokefree 2025, but we also encourage a vape-free nation.  One product should not simply be replacing the other, as both products are not without harm to the lungs.”

--ENDS--

 
1.  Ministry of Health. (2018). Annual Update of Key Results 2017/18: New Zealand Health Survey. Wellington: Ministry of Health.
 

For media enquiries please contact:
Judy McLuskie
Phone: 04 495 0091
Phone: 027 315 8763 
Email: judy@asthmaandrespiratory.org.nz
For more information visit: www.asthmaandrespiratory.org.nz

Fact Sheet:
 
Respiratory Disease 

  • Respiratory Disease in NZ 
  • Affects 700,000 people in New Zealand, costing $7 billion a year 
  • Causes 1 in 10 hospital stays, that’s 86,000 hospital admissions 
  • Third leading cause of death 
Asthma 
  • Asthma affects 1 in 8 adults and 1 in 7 children in New Zealand. We have one of the highest rates in the world. 
  • 77 people die from asthma each year, that is just over 1 person per week. 
  • By far the highest number of people being admitted to hospital with asthma are Māori, Pacific peoples and people living in the most deprived areas. Māori are 3.4 times and Pacific peoples 3.9 times more likely to be hospitalised than Europeans or other New Zealanders. People living in the most deprived areas are 3.7 times more likely to be hospitalised than those in the least deprived areas.
COPD 
  • 15% of New Zealanders over 45 have COPD, that’s 200,000 people 
  • 5,579 newly diagnosed people each year 
  • Most cases of COPD are linked to smoking 
Bronchiectasis
  • Hospitalisations have risen 49% from 2000-2017 
  • 123 children are diagnosed per year 
  • 1450 are hospitalised each year 
  • 116 people die from bronchiectasis each year 
Copyright © *2019* *ARFNZ*, All rights reserved.

Our mailing address is:
PO Box 1459, Wellington 6140

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

www.asthmaandrespiratory.org.nz